Breast Cancer Liquid Biopsy Trial
Status unconfirmed
Conditions studied: Breast Cancer, Cancer
In brief
The purpose of this study is to continue to develop a liquid biopsy (minimally invasive blood test) that can be used to confirm if breast cancer has spread throughout the body and if this liquid biopsy test can provide comparable information to a highly invasive tissue biopsy. The knowledge gained in this study could be used in future studies to confirm cancer recurrence using a safe and minimally invasive procedure. The research will consist of looking for tumor cell(s) circulating in the blood stream and if they are present to characterize them so that more information about the disease can be collected. This information may help us to better understand how to fight cancer.
Key facts
- Study ID
- NCT04962529
- Run by
- Anthony Magliocco
- People needed
- 450
- Starts
- 2020-09-28
- Expected to finish
- 2023-07-31
- Last updated by the study team
- 2022-08-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Miami Memorial Healthcare System — Hollywood, Florida, United States (enrolling)
- Ocala Oncology — Ocala, Florida, United States (enrolling)
- 6555 Sanger Rd, Suite 260 — Orlando, Florida, United States (enrolling)
- Sarasota Memorial Hospital — Sarasota, Florida, United States (enrolling)
- Northwest Community Hospital — Arlington Heights, Illinois, United States (enrolling)
- New York Cancer & Blood Specialists — New York, New York, United States (enrolling)
- Montefiore Medical Center — The Bronx, New York, United States (enrolling)
- Saskatoon City Hospital — Saskatoon, Saskatchewan, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.